HSY — The Hershey Company

The tape, not the fundamentals, is driving sentiment as of 2026-09-13: HSY is -20.16% over six months, -5.92% over one month, and sits below its 20-, 50- and 200-day moving averages (RSI 39.83). Price targets have been trimmed (DA Davidson to $190, RBC to $206, Bernstein to $201) on volume-elasticity and market-share concerns, and the sell-side consensus is a lukewarm Hold (9 buy / 23 hold / 3 sell). Even the positive Q2 2026 print (July 30: net sales $2.79B, +6.6% YoY, adjusted EPS $1.90, guidance raised) failed to lift the stock, which tells you the market is discounting the recovery as price/mix-driven rather than volume-driven. Notably, UBS still flags HSY as a crowded institutional long — so positioning is heavy into a weak tape, which cuts both ways.

Revenue has re-accelerated: four straight quarters of YoY growth (Q3'25 +6.5%, Q4'25 +7.0%, Q1'26 +10.6%, Q2'26 +6.6%), off a 2024 base that was roughly flat. But the real story is margins, and it is a clean V-shaped inflection, not a blip. Gross margin bottomed at 30.5% in Q2 2025 and has climbed every quarter since: 31.6% (Q3'25), 37.0% (Q4'25), 39.4% (Q1'26), 45.3% (Q2'26) — back to the mid-40s range that prevailed before the cocoa spike. Operating margin followed: 7.4% → 12.9% → 14.4% → 20.6% → 23.1%. Diluted EPS went $0.31 → $1.36 → $1.57 → $2.13 → $2.26 (Q2'26 GAAP; $1.90 adjusted). Free cash flow flipped from -$46.5M in Q2 2025 to $329.5M in Q2 2026, with TTM FCF of ~$1.94B. Caveat: Q1'24 and Q4'24 show anomalous ~32.5% operating margins that don't fit the pattern (likely one-off items), so YoY comparisons against 2024 are noisy — the clean read is the sequential recovery off the 2025 trough. Verdict: inflecting upward, with growth still leaning on price/mix rather than unit volume.

Mildly cheap versus its own history, not cheap in absolute terms. As of 2026-09-13 at $173.32, the trailing P/E is 23.49x on depressed TTM EPS of $7.495, which overstates the multiple — on the forward estimate of $8.494 the stock trades at ~20.4x, versus a 5-year average P/E of 26.78x. Price/sales is 2.89x against a 5-year average of 3.74x. The PEG ratio of -10.43 is meaningless (negative trailing growth). P/B of 7.55x and ROIC of just 9% are the two genuinely unflattering numbers — the book value is thin because of buybacks, and returns on capital aren't elite. The deterministic score's own valuation overlay labels this 'Cheap vs. its own history' (71.9), and the analyst consensus target of $204.62 sits ~18% above spot. Fair-to-modestly-cheap is the honest read: you're paying roughly 20x forward for a business that should compound EPS in the mid-single digits post-recovery, with a 3.1% dividend yield as a backstop.

The setup is classic 'multiple compression outrunning an earnings rebound.' Estimates have already moved up — full-year 2026 guidance was raised to $8.36–$8.52 (32.5–35% growth) — but the share price has moved down 20% over six months, so the forward multiple has compressed to ~20.4x from a historical ~26.8x. The market is either (a) underpricing the durability of the margin recovery, or (b) correctly discounting that the recovery is price/mix-led and that volumes could roll over once consumers push back on already-high chocolate shelf prices. The tell will be the Q3 2026 print and Halloween sell-through: if earnings beat and the multiple stays at 20x, the stock is mispriced; if volumes go negative and price realization stalls, the beat-and-lower pattern repeats and the multiple is right. Do not assume an EPS beat automatically lifts the stock — Hershey has just shown it can beat and still de-rate.

Bearish trend, not yet oversold enough to be a mechanical buy. As of 2026-09-13, RSI(14) was 39.83, price was -3.87% vs the 20-day SMA, -2.87% vs the 50-day, and -9.84% vs the 200-day — a clean downtrend with the 200-day acting as overhead resistance. The stock is 7.4% above its 52-week low of $161.43 and 27.6% below its 52-week high of $239.48, so it's closer to the floor than the ceiling but hasn't tested it. One-week return is +0.1%, i.e., the selling has at least paused. Practical read: no bottoming signal yet. A reclamation of the 50-day (~$178) and RSI back above 50 would be the first credible confirmation; a break of $161.43 opens the next leg down. Scaling in on weakness rather than chasing is the sensible posture.

• Cocoa prices: after spiking above $10,000/metric ton in early 2025 on West African crop failures, wholesale cocoa has retreated and stabilized, but remains volatile and structurally above pre-2024 levels — Hershey's hedges roll forward over the next several quarters, so input-cost relief is real but gradual.
• Consumer value-seeking: persistent inflation has pushed lower- and middle-income shoppers toward private label, and Hershey has kept chocolate retail prices high rather than passing through deflation, leaving volume elasticity stretched.
• Rates and the income trade: with a ~3.1% dividend yield, HSY competes with bond yields and is sensitive to the rate path — falling rates support staple multiples and the dividend's relative appeal; sticky rates cap re-rating.
• Sector rotation and crowding: staples have lagged, and UBS flags Hershey as a crowded long — heavy institutional ownership means rotation out of defensives can amplify drawdowns beyond what fundamentals justify.
• Long-term snacking shift: GLP-1 adoption and better-for-you preferences are a slow structural headwind to core confectionery volumes, partially offset by the salty/protein portfolio (SkinnyPop, Dot's, LesserEvil).

• Q3 2026 earnings release (expected late October/early November 2026) — the first real test of back-to-school demand and early Halloween sell-through, and whether the raised $8.36–$8.52 EPS guidance survives contact with volume data.
• Halloween and winter-holiday inventory build/sell-through — Hershey's most seasonal profit window, and the single biggest swing factor in second-half results.
• Further cocoa price normalization (or a re-spike) as hedges roll and the 2027 cost base is set.
• Execution under new CFO Dave Hulays (effective 2026-09-02) and the ONE Hershey unified operating model, plus the $500M incremental buyback authorized in Q2 2026 and the restored dividend.

• Cocoa re-spike or hedge roll-over at unfavorable prices re-compressing gross margins — the 2025 experience (gross margin 30.5%) shows how violent this can be.
• Volume and market-share erosion: growth is currently price/mix-led, and private label plus competitors (Mars, Mondelez) are taking unit share as consumers resist high shelf prices.
• Balance sheet: D/E of 1.23, current ratio of 1.18, quick ratio of 0.66, and ~$3.9B of net debt against ~$1.94B TTM FCF — manageable, but tight enough to limit flexibility if input costs spike again.
• Valuation is only cheap relative to its own inflated history — at 7.5x P/B and 2.9x P/S it still carries an absolute premium to most staple peers, leaving room to de-rate further if growth disappoints.
• Technical downtrend plus crowded long positioning: price is below all key moving averages, and a sustained break of the $161.43 52-week low could force institutional de-risking.

Hershey is a genuinely improving business in a genuinely ugly chart. The cocoa-cost crisis that gutted 2025 (Q2'25 operating margin 7.4%, EPS $0.31, negative FCF) is resolving — Q2 2026 operating margin hit 23.1%, gross margin 45.3%, and full-year EPS guidance was raised to $8.36–$8.52 — yet the stock trades 20% lower over six months at ~20.4x forward earnings versus a 26.8x five-year average. That gap is the opportunity. The catch is that the recovery is price/mix-led with soft volumes, the balance sheet is levered, and momentum is still pointed down. This is a reasonable accumulate-on-weakness name for a patient, income-oriented investor — not a compelling buy at $173.32 with no technical confirmation, and not a sell given the earnings inflection and 'cheap vs. its own history' valuation.

Applied ~22x to the next-FY consensus EPS estimate of $8.494, a deliberate discount to Hershey's 5-year average P/E of 26.78x (justifying it with low-single-digit organic growth and structurally higher cocoa volatility) but a premium to the ~20.4x forward multiple implied by the 2026-09-13 price of $173.32, reflecting the margin/EPS recovery already visible in the trailing quarters. Cross-checked against ~$9.55/share of trailing free cash flow at a ~5% required FCF yield (~$191) and a discounted 3.2x P/S on ~$60.64 of forward sales per share (~$194), which bracket the estimate; blended to $186.